FDCDDQ
ACHN

Federation des caisses Desjardins du Quebec’s Achillion Pharmaceuticals ACHN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-900
Closed -$3.34K – 2273
2018
Q1 		$3.34K Hold
900
– – ﹤0.01% 1942
2017
Q4 		$2.59K Hold
900
– – ﹤0.01% 1969
2017
Q3 		$4.04K Hold
900
– – ﹤0.01% 1862
2017
Q2 		$4.13K Hold
900
– – ﹤0.01% 1917
2017
Q1 		$3.79K Buy
+900
New +$3.74K ﹤0.01% 1586

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ACHN Position: Q2 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Achillion Pharmaceuticals (ACHN) in Q2 2018, closing a stake of 900 shares — an estimated $3.34K sold.

Federation des caisses Desjardins du Quebec first reported a position in ACHN in Q1 2017 and held it in 5 quarters. The position peaked at $4.13K in Q2 2017. 124 funds tracked by Wall St. Rank hold ACHN as of Q2 2018.

  • Federation des caisses Desjardins du Quebec reported no remaining Achillion Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 900 Achillion Pharmaceuticals shares in Q2 2018, an estimated $3.34K.
  • Federation des caisses Desjardins du Quebec first reported a position in Achillion Pharmaceuticals in Q1 2017 and held it in 5 quarters.
  • Federation des caisses Desjardins du Quebec's Achillion Pharmaceuticals position peaked at $4.13K in Q2 2017.
  • 124 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2018, filed 30 Aug 2024.